HOME >> MEDICINE >> NEWS
Synthetic progestin damages, estrogen protects blood vessels in animal model

TAMPA (11 Dec 2003) -- Synthetic progestins may be the major cause of harmful side effects reported with hormone replacement therapy. University of South Florida researchers used a novel imaging technique to show that progestins caused toxicity while natural progesterone and estrogen did not show toxicity to blood vessels in live animals.

"Our findings can lead to the development and screening of synthetic hormones to find a safe progestin that will ultimately give women safer options than are currently available for hormone replacement therapy," said Tom Thomas, MD, PhD, co-principal investigator and lead author of the study published today in Climacteric, the Journal of the International Menopause Society.

"This is experimental evidence that supports scientists who believe estrogen with the right formulation is good for some women, depending on their other risk factors."

The novel imaging technique was developed by Thomas and Johannes Rhodin, MD, PhD, co-principal investigator. It took three years for Thomas and Rhodin to combine video microscopy with fluorescence and electron microscopy. By labeling blood cells with a fluorescent tag, the team observed blood flow, blood vessel structure and activities of various blood cells in real time in a live animal. After one dose of medroxy progesterone acetate (MPA), the most widely used synthetic progestin in estrogen prepaparations and oral contraceptives, the rats had visible damage to the periphery and brain blood vessels, endothelial and smooth muscle damage, inflammation and blood clot formation and impeded blood flow.

These vascular reactions to synthetic progestin can lead to increases in heart attacks, blood clots, strokes and dementia--problems that were observed in the Women's Health Initiative," Thomas said.

The USF researchers' findings may shed light on the current reassessment of the National Institute of Health-sponsored Women's Health Initiative.

Using the sa
'"/>

Contact: Marissa Emerson
memerson@hsc.usf.edu
813-974-3300
University of South Florida Health
11-Dec-2003


Page: 1 2

Related medicine news :

1. Synthetic marijuana reduces agitation in patients with Alzheimers
2. Synthetic marijuana compound reduces agitation, improves appetite in Alzheimers patients
3. Synthetic rubber kills germs on contact
4. Views Of Tamoxifen And Synthetic Estrogen In Action Provide Clues For Designing Better Drugs
5. UCSF Study In Rats Suggests Synthetic Drug Mimicking Marijuana Might Be Used To Treat Pain
6. "Green Chemistry" Cleans Up Environment And Renders Synthetic Drugs
7. Synthetic Detergent Found To Fight Multi-Drug Resistance
8. Estrogren plus progestin decreases colorectal cancer in postmenopausal woman
9. High estrogen/progestin levels may reduce asthma severity, say Pittsburgh researchers
10. Changing chemistry helps explain estrogen threat to the heart
11. Use of estrogen therapy may increase risk for gallbladder disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)... ... 2017 , ... Floundering on New Year’s resolutions? Need an excuse to get ... reset. The U.S. Apple Association agrees and recommends starting each day with apples, ... to heart disease. , The U.S. Apple Association – which represents apple growers and ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... difference. Eden Activewear is a stand-out company for several differences from other mainstream ... only manufacture on demand, this is called 'Agile' manufacturing - http://www.leanproduction.com/agile-manufacturing.html . ...
(Date:1/17/2017)... Fla (PRWEB) , ... January 17, 2017 , ... SunView ... Excellence Award for Innovation of the Year. , Each year, Pink Elephant ... taken an innovative approach to address a specific business problem or opportunity. The award ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... as Palm Desert, is opening a new office in San Clemente, California this ... stimulation (dTMS) in Southern California, successfully treating individuals struggling with major depression. Depression ...
(Date:1/17/2017)... York (PRWEB) , ... January 17, 2017 , ... ... – SightMD – will lecture to primary eye care practitioners on the latest ... at the upcoming 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... and Markets has announced the addition of the "Vital Signs Monitoring ... Industry Forecast, 2014-2022" report to their offering. ... Vital signs monitoring market size was worth $3,694 ... growing at a CAGR of 5.8% from 2016 to 2022. ... in global vital signs monitoring devices industry. The blood pressure monitoring devices ...
(Date:1/18/2017)... 2017   Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies to ... reported the Company,s operating results for 2016 and an ... the Company described in its recent 10-K filing with ... accomplishments. The Company,s contract laboratory completed its evaluation of ...
(Date:1/18/2017)... 18, 2017 Research and Markets has announced ... Market 2017-2021" report to their offering. ... The global CINV drugs market to ... Global Thoracic Surgery Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Medicine Technology:
Cached News: